Patricia Drake
Corporate Officer/Principal bei TREVENA, INC.
Vermögen: 41 760 $ am 31.05.2024
Profil
Patricia Drake is currently the Chief Commercial Officer & Senior Vice President at Trevena, Inc. Prior to this, she was the Chief Executive Officer & Managing Director at MSD Finland Oy from 2019 to 2021, and the Chief Commercial Officer at Sesen Bio, Inc. in 2021.
She completed her undergraduate degree at Wichita State University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
TREVENA, INC.
0,58% | 14.12.2023 | 107 078 ( 0,58% ) | 41 760 $ | 31.05.2024 |
Aktive Positionen von Patricia Drake
Unternehmen | Position | Beginn |
---|---|---|
TREVENA, INC. | Corporate Officer/Principal | 11.11.2021 |
Ehemalige bekannte Positionen von Patricia Drake
Unternehmen | Position | Ende |
---|---|---|
CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 01.09.2021 |
MSD Finland Oy | Vorstandsvorsitzender | 01.05.2021 |
Ausbildung von Patricia Drake
Wichita State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TREVENA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
MSD Finland Oy | |
Sesen Bio, Inc.
Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |